Dodd, Seetal

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 1,178

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 731

N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility

Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy

Drug-Induced Hepatotoxicity and ProtectionSulfur Compounds in Biology

Cited by 413

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

Berk, M., Dodd, S., Kauer‐Sant’Anna, M., Malhi, G. S., Bourin, M., Kapczinski, F., & Norman, T. (2007) · Acta Psychiatrica Scandinavica

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 396

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

Fernandes, B. S., Steiner, J., Bernstein, H.-G., Dodd, S., Pasco, J. A., Dean, O. M., Nardin, P., Gonçalves, C.-A., & Berk, M. (2016) · Molecular Psychiatry

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 348

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 336

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use

Berk, M., Ng, F., Dodd, S., Callaly, T., Campbell, S., Bernardo, M., & Trauer, T. (2008) · Journal of Evaluation in Clinical Practice

Psychiatric care and mental health servicesPsychological Testing and Assessment

Cited by 280

Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses

Hawton, K., Bergen, H., Simkin, S., Dodd, S., Pocock, P., Bernal, W., Gunnell, D., & Kapur, N. (2013) · BMJ

Poisoning and overdose treatmentsOpioid Use Disorder Treatment

Cited by 273

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., et al. (2016) · The Lancet Psychiatry

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 247

Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force.

Frey, B. N., Andreazza, A. C., Houenou, J., Jamain, S., Goldstein, B. I., Frye, M. A., Leboyer, M., Berk, M., Malhi, G. S., Lopez-Jaramillo, C., et al. (2013) · Australian & New Zealand Journal of Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 234

History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder

Berk, M., Dodd, S., Callaly, P., Berk, L., Fitzgerald, P., de Castella, A. R., Filia, S., Filia, K., Tahtalian, S., Biffin, F., et al. (2007) · Journal of Affective Disorders

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 217

Staging in bipolar disorder: from theoretical framework to clinical utility

Berk, M., Post, R., Ratheesh, A., Gliddon, E., Singh, A., Vieta, E., Carvalho, A. F., Ashton, M. M., Berk, L., Cotton, S. M., et al. (2017) · World Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 216

Glutathione: a novel treatment target in psychiatry

Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences

Sulfur Compounds in BiologyRedox biology and oxidative stress

Cited by 183

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

Berk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 181

The Efficacy of Adjunctive N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 172

Stage managing bipolar disorder

Berk, M., Berk, L., Dodd, S., Cotton, S., Macneil, C., Daglas, R., Conus, P., Bechdolf, A., Moylan, S., & Malhi, G. S. (2014) · Bipolar Disorders

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 163

Annual high-dose vitamin D3and mental well-being: randomised controlled trial

Sanders, K. M., Stuart, A. L., Williamson, E. J., Jacka, F. N., Dodd, S., Nicholson, G., & Berk, M. (2011) · British Journal of Psychiatry

Vitamin D Research StudiesNutrition and Health Studies

Cited by 145

The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment

Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry

Treatment of Major DepressionMitochondrial Function and Pathology

Cited by 140

Bipolar II disorder: a review

Berk, M., & Dodd, S. (2005) · Bipolar Disorders

Bipolar Disorder and TreatmentPersonality Disorders and Psychopathology

Cited by 134

Results of the COVID-19 mental health international for the general population (COMET-G) study

Fountoulakis, K. N., Karakatsoulis, G., Abraham, S., Adorjan, K., Ahmed, H. U., Alarcón, R. D., Arai, K., Auwal, S. S., Berk, M., Bjedov, S., et al. (2022) · European Neuropsychopharmacology

COVID-19 and Mental HealthMental Health Treatment and Access

Cited by 134

Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function

Hodge, J. M., Wang, Y., Berk, M., Collier, F. M., Fernandes, T. J., Constable, M. J., Pasco, J. A., Dodd, S., Nicholson, G. C., Kennedy, R. L., et al. (2013) · Biological Psychiatry

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 122

Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials

Salagre, E., Fernandes, B. S., Dodd, S., Brownstein, D. J., & Berk, M. (2016) · Journal of Affective Disorders

Treatment of Major DepressionLipoproteins and Cardiovascular Health

Cited by 117

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

Williams, L. J., Henry, M. J., Berk, M., Dodd, S., Jacka, F. N., Kotowicz, M. A., Nicholson, G. C., & Pasco, J. A. (2008) · International Clinical Psychopharmacology

Bone health and osteoporosis researchTreatment of Major Depression

Cited by 117

The effects of physical activity in the acute treatment of bipolar disorder: A pilot study

Ng, F., Dodd, S., & Berk, M. (2007) · Journal of Affective Disorders

Bipolar Disorder and TreatmentPhysical Activity and Health

Cited by 113